Literature DB >> 10024600

Specificity and function of immunogenic peptides from the 35-kilodalton protein of Mycobacterium leprae.

R J Wilkinson1, K A Wilkinson, S Jurcevic, A Hills, S Sinha, U Sengupta, D N Lockwood, K Katoch, D Altman, J Ivanyi.   

Abstract

We identified a T-cell determinant of the 35-kDa antigen of Mycobacterium leprae which is discriminatory against cross-sensitization by its closely related homologue in Mycobacterium avium. From synthetic peptides covering the entire sequence, those with the highest affinity and permissive binding to purified HLA-DR molecules were evaluated for the stimulation of proliferation of peripheral blood mononuclear cells (PBMCs) from leprosy patients and healthy sensitized controls. Responses to the peptide pair 206-224, differing by four residues between M. leprae and M. avium, involved both species-specific and cross-reactive T cells. Lymph node cell proliferation in HLA-DRB1*01 transgenic mice was reciprocally species specific, but only the response to the M. leprae peptide in the context of DR1 was immunodominant. Of the cytokines in human PBMC cultures, gamma interferon production was negligible, while interleukin 10 (IL-10) responses in both patients and controls were more pronounced. IL-10 was most frequently induced by the shared 241-255 peptide, indicating that environmental cross-sensitization may skew the response toward a potentially pathogenic cytokine phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024600      PMCID: PMC96486          DOI: 10.1128/IAI.67.3.1501-1504.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line.

Authors:  J C Gorga; V Horejsí; D R Johnson; R Raghupathy; J L Strominger
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

2.  Identification of an immunostimulating protein from Mycobacterium leprae.

Authors:  N Mohagheghpour; M W Munn; R H Gelber; E G Engleman
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Use of the HLA-DR antigens incorporated into liposomes to generate HLA-DR specific cytotoxic T lymphocytes.

Authors:  J C Gorga; J Foran; S J Burakoff; J L Strominger
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

4.  The major native proteins of the leprosy bacillus.

Authors:  S W Hunter; B Rivoire; V Mehra; B R Bloom; P J Brennan
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

5.  Heterogeneity of serological responses in paucibacillary leprosy--differential responses to protein and carbohydrate antigens and correlation with clinical parameters.

Authors:  P W Roche; W J Britton; S S Failbus; H Ludwig; W J Theuvenet; R B Adiga
Journal:  Int J Lepr Other Mycobact Dis       Date:  1990-06

6.  Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis.

Authors:  R J Wilkinson; K A Wilkinson; K A De Smet; K Haslov; G Pasvol; M Singh; I Svarcova; J Ivanyi
Journal:  Scand J Immunol       Date:  1998-10       Impact factor: 3.487

7.  Homologs of Mycobacterium leprae 18-kilodalton and Mycobacterium tuberculosis 19-kilodalton antigens in other mycobacteria.

Authors:  R J Booth; D L Williams; K D Moudgil; L C Noonan; P M Grandison; J J McKee; R L Prestidge; J D Watson
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells.

Authors:  A A Janson; P R Klatser; R van der Zee; Y E Cornelisse; R R de Vries; J E Thole; T H Ottenhoff
Journal:  J Immunol       Date:  1991-11-15       Impact factor: 5.422

9.  Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi.

Authors:  J M Pönnighaus; P E Fine; J A Sterne; R J Wilson; E Msosa; P J Gruer; P A Jenkins; S B Lucas; N G Liomba; L Bliss
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

10.  Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.

Authors:  P A Sieling; J S Abrams; M Yamamura; P Salgame; B R Bloom; T H Rea; R L Modlin
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

View more
  4 in total

1.  A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents.

Authors:  H M Dockrell; S Brahmbhatt; B D Robertson; S Britton; U Fruth; N Gebre; M Hunegnaw; R Hussain; R Manandhar; L Murillo; M C Pessolani; P Roche; J L Salgado; E Sampaio; F Shahid; J E Thole; D B Young
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.

Authors:  John S Spencer; Hee Jin Kim; William H Wheat; Delphi Chatterjee; Marivic V Balagon; Roland V Cellona; Esterlina V Tan; Robert Gelber; Paul Saunderson; Malcolm S Duthie; Stephen T Reece; William Burman; Robert Belknap; William R Mac Kenzie; Annemieke Geluk; Linda Oskam; Hazel M Dockrell; Patrick J Brennan
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

3.  Antigenic specificity of the Mycobacterium leprae homologue of ESAT-6.

Authors:  John S Spencer; Maria Angela M Marques; Monica C B S Lima; Ana Paula Junqueira-Kipnis; Bruce C Gregory; Richard W Truman; Patrick J Brennan
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.

Authors:  Sune Justesen; Mikkel Harndahl; Kasper Lamberth; Lise-Lotte B Nielsen; Søren Buus
Journal:  Immunome Res       Date:  2009-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.